Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.7B |
| 2 |
ATVI
Activision Blizzard
ATVI
|
+$907M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$644M |
| 4 |
NVIDIA
NVDA
|
+$440M |
| 5 |
CRH
CRH
|
+$429M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$689M |
| 2 |
Home Depot
HD
|
+$377M |
| 3 |
Cigna
CI
|
+$322M |
| 4 |
Valero Energy
VLO
|
+$250M |
| 5 |
Amphenol
APH
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 55.35% |
| 2 | Technology | 9.23% |
| 3 | Healthcare | 7.6% |
| 4 | Financials | 5.15% |
| 5 | Consumer Discretionary | 5.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
CALL
PNC Financial Services
PNC
$96.6B
| $5.77M | ﹤0.01% |
47,000
-38,700
| -45% | -$4.87M |
|
|
SEM
2502
DELISTED
Select Medical
SEM
| $5.77M | ﹤0.01% |
423,780
+235,491
| +125% | +$3.64M |
|
2503
CALL
Abercrombie & Fitch
ANF
$6.59B
| $5.76M | ﹤0.01% |
+102,200
| New | +$4.54M |
|
2504
PUT
TripAdvisor
TRIP
$1.16B
| $5.76M | ﹤0.01% |
347,400
+32,400
| +10% | +$529K |
|
2505
Conduent
CNDT
$267M
| $5.75M | ﹤0.01% |
1,653,730
+579,207
| +54% | +$1.93M |
|
2506
CALL
Akamai
AKAM
$15.4B
| $5.74M | ﹤0.01% |
53,900
-50,000
| -48% | -$4.98M |
|
2507
CALL
Stellantis
STLA
$20.4B
| $5.74M | ﹤0.01% |
300,100
-382,500
| -56% | -$7.16M |
|
|
SA
2508
Seabridge Gold
SA
$3.49B
| $5.74M | ﹤0.01% |
543,714
-363,027
| -40% | -$4.31M |
|
|
NOVA
2509
DELISTED
Sunnova Energy
NOVA
| $5.73M | ﹤0.01% |
547,485
+530,854
| +3,192% | +$8.3M |
|
2510
Vishay Precision Group
VPG
$833M
| $5.73M | ﹤0.01% |
170,637
-2,861
| -2% | -$102K |
|
2511
CALL
Corning
GLW
$128B
| $5.73M | ﹤0.01% |
187,900
+64,800
| +53% | +$2.12M |
|
|
BNY
2512
Bank of New York Mellon
BNY
$110B
| $5.72M | ﹤0.01% |
134,181
-2,427,944
| -95% | -$108M |
|
2513
News Corp Class A
NWSA
$16.6B
| $5.72M | ﹤0.01% |
285,264
-219,100
| -43% | -$4.44M |
|
2514
CALL
GSK
GSK
$102B
| $5.72M | ﹤0.01% |
157,800
-192,300
| -55% | -$6.83M |
|
2515
PUT
Colgate-Palmolive
CL
$72.3B
| $5.71M | ﹤0.01% |
80,300
-49,200
| -38% | -$3.68M |
|
2516
Grupo Cibest SA
CIB
$23B
| $5.7M | ﹤0.01% |
213,699
-230,123
| -52% | -$6.39M |
|
2517
Moderna
MRNA
$55.1B
| $5.69M | ﹤0.01% |
55,061
-105,902
| -66% | -$11.8M |
|
2518
CALL
Zions Bancorporation
ZION
$9.89B
| $5.69M | ﹤0.01% |
+163,000
| New | +$5.68M |
|
2519
IBM
IBM
$222B
| $5.69M | ﹤0.01% |
40,535
-341,665
| -89% | -$48.6M |
|
2520
Installed Building Products
IBP
$6.53B
| $5.68M | ﹤0.01% |
45,501
+21,852
| +92% | +$3.09M |
|
2521
Vistra
VST
$46B
| $5.68M | ﹤0.01% |
171,232
-2,509,330
| -94% | -$75.4M |
|
|
PNT
2522
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $5.68M | ﹤0.01% |
+851,735
| New | +$7.08M |
|
|
ESPR
2523
DELISTED
Esperion Therapeutics
ESPR
| $5.68M | ﹤0.01% |
5,794,029
+2,447,303
| +73% | +$3.54M |
|
2524
iHeartMedia
IHRT
$426M
| $5.68M | ﹤0.01% |
1,795,998
-119,001
| -6% | -$449K |
|
2525
Vertex
VERX
$2.31B
| $5.66M | ﹤0.01% |
244,927
-560,791
| -70% | -$11.5M |
|
Similar funds
Israel Englander's Q3 2023 Portfolio in Review
As of Q3 2023, Israel Englander held 6,895 positions worth $198B, down 2.3% from $203B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Israel Englander deployed $6.14B of net new capital in Q3 2023, opening 836 new positions and adding to 2,326 existing holdings. Its largest new stake was Mobileye: 2,953,164 shares worth $123M.
By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, down from 56% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was iShares Core S&P 500 ETF, an estimated $689M trimmed.
- Israel Englander's largest Q3 2023 buy was Mobileye: 2,953,164 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q3 2023, an estimated $3.7B increase.
- Israel Englander's biggest Q3 2023 reduction was iShares Core S&P 500 ETF, cutting an estimated $689M.
- Israel Englander fully exited Blackstone in Q3 2023, selling an estimated $178M.
- Israel Englander's ten largest holdings make up 21% of its $198B portfolio in Q3 2023.
- Israel Englander opened 836 new positions and closed 834 in Q3 2023.
- Israel Englander's portfolio value fell 2.3% quarter-over-quarter to $198B.
Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.